[
    [
        {
            "time": "2018-01-16",
            "original_text": "格隆汇港股聚焦(1.16)︱中国平安2018年原保费收入升18.94%至7191.44亿元",
            "features": {
                "keywords": [
                    "中国平安",
                    "2018年",
                    "原保费收入",
                    "增长",
                    "18.94%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "保险"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(1.16)︱中国平安2018年原保费收入升18.94%至7191.44亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-16",
            "original_text": "复星医药子公司治疗敏感结核病药品通过一致性评价",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "药品",
                    "一致性评价",
                    "敏感结核病"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药子公司治疗敏感结核病药品通过一致性评价",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-16",
            "original_text": "润灵全球责任评级：2018年，851家A股上市公司披露CSR报告，CSR信息披露十年增长1.29倍",
            "features": {
                "keywords": [
                    "润灵全球责任评级",
                    "2018年",
                    "A股上市公司",
                    "CSR报告",
                    "增长",
                    "1.29倍"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "社会责任"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "润灵全球责任评级：2018年，851家A股上市公司披露CSR报告，CSR信息披露十年增长1.29倍",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-16",
            "original_text": "【权益变动】复星医药(02196-HK)获复星国际增持36.55万股",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星国际",
                    "增持",
                    "36.55万股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【权益变动】复星医药(02196-HK)获复星国际增持36.55万股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]